Frequency of metabolic syndrome and 25-hydroxyvitamin D3 levels in patients with non-alcoholic fatty liver disease

Minerva Medica

Volumn 104, Issue 4, 2013, Pages 447-453

  Eraslan, S ^a   Kizilgul, M ^a   Uzunlulu, M ^a   Colak, Y ^a   Ozturk, O ^a   Tuncer, I ^a  

^a Radiology Department   (Turkey)

Author keywords

Fatty liver; Insulin resistance; Metabolic syndrome X

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CALCIFEDIOL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LACTATE DEHYDROGENASE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER BIOPSY; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PATHOGENESIS; SYSTOLIC BLOOD PRESSURE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; BIOLOGICAL MARKERS; BIOPSY; CALCIFEDIOL; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; LIVER; MALE; METABOLIC SYNDROME X;

EID: 84886687873     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ludwig J, Viggiano T, McGill D, Oh BJ. Nonalkolic steatohepatitis, Mayo clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-8.
2. Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. clinical features and natural history of non-alcholic steatosis syndromes. Seminars in Liver Disease 2001;21:17-26.
3. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N et al. Nonalcoholic steatohepatitis, insülin resistance and metabolic syndrom: further evidence for an etiologic assosiation. Hepatology 2002;35:367-72.
4. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C et al. NASH and insülin resistance: insülin hypersecretion and specific assosiation with the insülin resistance syndrom. Hepatology 2002;35:373-9.
5. Day C, Saksena S. Nonalcoholic steatohepatitis: definitions and pathogenesis. J Gastroenterol Hepatol 2002;17:377-84.
6. Xiong MA, Zhiping LI. Sisheaansegshai Branch Pathogenesis of nonalcoholic steatohepatitis. Chin J Dig Dis 2006;7:7-11.
7. Grundy SM. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 2006;47:1093-100.
8. Brown A, Dusso A, Slatopolsky E. Vitamin D. Am J Physiol 1999;277:157-75.
9. Norman PE, Powell JT. Vitamin D, shedding light on the development of disease in peripheral arteries. Arterioscler Thromb Vasc Biol 2005;25:39-46.
10. Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe-Court D et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanism for inflammatory damage in chronic disorders? Q J Med 2002;95:787-96.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
12. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469-80.
13. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-21.
14. Willheim M, Thien R, Schrattbauer K, Bajna F, Holub M, Gruber R et al. Regulatory effects of 1-alpha 25 dihydroxyvitamin D3 on the cytokine production of human peripheral blood lymphocytes. J Clin Endocrinol Metab 1999;84:3739-44.
15. Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insülin secretion and peripheral insülin sensitivity in type 2 diabetic patients. Intern J Clin Pract 2003;57:258-61.
16. Mak RH, Wong JH. The vitamin D/parathyroid hormone axis in the pathogenesis of hypertension and insulin resistance in uremia. Min Electr Metab 1992;18:156-9.
17. Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patientswith non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2007;17:517-24.
18. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917-23.
19. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K et al. The Metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005;143:722-8.